| GTO ID | GTC2535 |
| Trial ID | NCT04665076 |
| Disease | Plasma Cell Neoplasm |
| Therapy | CAR-T cell |
| Treatment | Auto CAR-T |
| Recruitment status | Recruiting |
| Title | Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors |
| Year | 2020 |
| Country | China |
| Company sponsor | Hebei Senlang Biotechnology Inc., Ltd. |
| Other ID(s) | 2020104 |
| Cohort 1 | |||||||||||
|
|||||||||||